Annual Shareholders Equity
-$225.72 M
-$33.44 M-17.39%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual stockholders equity is currently -$225.72 million, with the most recent change of -$33.44 million (-17.39%) on 31 December 2023. ZBIO annual shareholders equity is now -17.39% below its all-time high of -$192.29 million, reached on 31 December 2022.ZBIO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$359.44 M
+$648.22 M+224.47%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly stockholders equity is currently $359.44 million, with the most recent change of +$648.22 million (+224.47%) on 30 September 2024. Over the past year, it has increased by +$561.67 million (+277.73%). ZBIO quarterly shareholders equity is now at all-time high.ZBIO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.4% | +277.7% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ZBIO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.4% | at low | at high | +224.5% |
| 5 y | 5 years | -17.4% | at low | at high | +224.5% |
| alltime | all time | -17.4% | at low | at high | +224.5% |
ProShares UltraPro Short Nasdaq Biotechnology Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $359.44 M(-224.5%) |
| June 2024 | - | -$288.78 M(+14.4%) |
| Mar 2024 | - | -$252.50 M(+11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$225.72 M(+17.4%) | -$225.72 M(+11.6%) |
| Sept 2023 | - | -$202.23 M |
| Dec 2022 | -$192.29 M | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual stockholders equity?
- What is the all time high annual shareholders equity for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual shareholders equity year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly shareholders equity year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual stockholders equity?
The current annual shareholders equity of ZBIO is -$225.72 M
What is the all time high annual shareholders equity for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual stockholders equity is -$192.29 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual shareholders equity year-on-year change?
Over the past year, ZBIO annual stockholders equity has changed by -$33.44 M (-17.39%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly stockholders equity?
The current quarterly shareholders equity of ZBIO is $359.44 M
What is the all time high quarterly shareholders equity for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly stockholders equity is $359.44 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly shareholders equity year-on-year change?
Over the past year, ZBIO quarterly stockholders equity has changed by +$561.67 M (+277.73%)